FOLR1 Enhances the Radioresistance of Gastric Cancer Via the Rescue of Damaged DNA

Lei Liu,Tian yang,Siting Yu,Zhongzheng Xiang,Yuanyuan Zeng,Jun Wang,Liping Bai,Zelei Dai,Ningyue Xu,Qinjie Wu,Changyang Gong

DOI: https://doi.org/10.21203/rs.3.rs-4749180/v1

2024-01-01

Abstract:Gastric cancer (GC) is a multifactorial malignancy with high incidence and mortality rates worldwide. Radiotherapy plays a crucial role in the comprehensive treatment of GC patients; however, its clinical benefits are still limited due to radioresistance. FOLR1 is known to predict poor prognosis in tumor patients and is involved in various biological processes, such as cell proliferation and apoptosis. However, its role in GC radioresistance has not been previously described. In this study, we investigated the role of FOLR1 in GC radioresistance through cell proliferation, apoptosis, migration and invasion assays using three GC cell lines (MKN-45, AGS, and MGC-803) and radiation-induced radioresistant GC cell line SGC-R. The results showed that FOLR1 was highly expressed in the radioresistant cell line SGC-R. Furthermore, we found that FOLR1/TPM4 activated the JAK1/STAT1 pathway, developed abnormal DNA damage response (DDR), and promoted GC radioresistance. Moreover, silencing FOLR1 increased sensitivity to ionizing radiation both in vitro and in vivo. Overall, FOLR1 is a novel biomarker for GC radioresistance and provides a potential therapeutic target for overcoming radioresistance in GC patients.